Reasons to Add GMED Stock to Your Portfolio Right Now

Globus Medical, Inc.’s (GMED) growth in the third quarter can be attributed to the robust prospect in the musculoskeletal space. The company’s merger with NuVasive is expected to generate significant synergies. Additionally, a strong liquidity position bodes well. Meanwhile, the impact of fierce competition raises concerns about the company’s operational results.This Zacks Rank #2 (Buy) company has delivered an impressive market performance in the past year. GMED’s shares have surged 54.9%, outpacing the in ...